SBI-0640726
SBI-0640726 is an eIF4G1 inhibitor with antiproliferative activity in melanoma. SBI-0640726 disrupts the eIF4F translation initiation complex by inhibiting AKT and NF-kB signaling pathways. SBI-0640726 inhibits the growth of NRAS and BRAF mutant melanoma in vitro[1].
Product Specifications
CAS Number
1321827-45-5
UNSPSC
12352005
Target
Akt; Eukaryotic Initiation Factor (eIF) ; NF-κB
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; NF-κB; PI3K/Akt/mTOR
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/sbi-0640726.html
Smiles
O=C(C1=C(C2=CC=CC=C2)C3=C(C=CC(Cl)=C3)NC1=O)/C=C/C4=CC=CC=N4
Molecular Formula
C23H15ClN2O2
Molecular Weight
386.83
References & Citations
[1]Yongmei Feng, et al. "SBI-0640756 attenuates the growth of clinically unresponsive melanomas by disrupting the eIF4F translation initiation complex." Cancer research 75.24 (2015) : 5211-5218.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
